ATE497782T1 - Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie - Google Patents

Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie

Info

Publication number
ATE497782T1
ATE497782T1 AT05735623T AT05735623T ATE497782T1 AT E497782 T1 ATE497782 T1 AT E497782T1 AT 05735623 T AT05735623 T AT 05735623T AT 05735623 T AT05735623 T AT 05735623T AT E497782 T1 ATE497782 T1 AT E497782T1
Authority
AT
Austria
Prior art keywords
gluten
egg yolk
zoeliacia
treating
yolk antibodies
Prior art date
Application number
AT05735623T
Other languages
English (en)
Inventor
Hoon Sunwoo
Jeong S Sim
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Application granted granted Critical
Publication of ATE497782T1 publication Critical patent/ATE497782T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05735623T 2004-04-16 2005-04-18 Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie ATE497782T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52139404P 2004-04-16 2004-04-16
PCT/CA2005/000593 WO2005099753A1 (en) 2004-04-16 2005-04-18 Anti-gluten egg yolk antibodies for the treatment of celiac disease

Publications (1)

Publication Number Publication Date
ATE497782T1 true ATE497782T1 (de) 2011-02-15

Family

ID=35149778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05735623T ATE497782T1 (de) 2004-04-16 2005-04-18 Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie

Country Status (6)

Country Link
US (1) US7854942B2 (de)
EP (1) EP1765395B1 (de)
AT (1) ATE497782T1 (de)
CA (1) CA2561800C (de)
DE (1) DE602005026287D1 (de)
WO (1) WO2005099753A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071101B2 (en) * 2005-11-03 2011-12-06 Avaxia Biologics, Inc. Antibody therapy for treatment of diseases associated with gluten intolerance
MX2008006233A (es) 2005-11-14 2008-10-03 Valorisation Rech Ltd Partners Composiciones farmaceuticas que comprenden aglutinantes polimericos con enlaces covalentes no hidrlizables y su uso en el tratamiento de la enfermedad celiaca.
JP5535638B2 (ja) * 2006-10-25 2014-07-02 ウィスコンシン アルムニ リサーチ ファンデイション リン酸塩吸収の低減方法
US8282928B2 (en) 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
WO2009020748A2 (en) 2007-07-16 2009-02-12 Avaxia Biologics, Inc. Antibody therapy for modulating function of intestinal receptors
WO2009046168A1 (en) 2007-10-02 2009-04-09 Avaxia Biologics, Inc. Antibody therapy for use in the digestive tract
CN102884079B (zh) * 2010-08-03 2014-12-10 华肝基因股份有限公司 治疗肝炎病毒感染的组合物及方法
KR101024297B1 (ko) * 2010-08-11 2011-03-29 유익종 유산 발효에 의해 계란단백질의 항원성이 저하된 유산발효계란 및 그의 제조방법
JP6652353B2 (ja) * 2015-09-09 2020-02-19 任天堂株式会社 通信装置および電池蓋
BR112018010629A2 (pt) * 2015-11-27 2018-11-27 Ericsson Telefon Ab L M método e transmissor ofdm para transmissões multiprotocolo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357272A (en) 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4550019A (en) 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US4748018A (en) 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US5849349A (en) 1982-06-03 1998-12-15 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
EP0225254B1 (de) 1985-11-25 1994-03-16 Ghen Corporation Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
CA2267421A1 (en) 1996-10-02 1998-04-09 Marilyn A. Coleman Oral administration of chicken yolk antibodies to treat disease
EP0905518A1 (de) * 1997-09-23 1999-03-31 Academisch Ziekenhuis Leiden Peptiden spezifisch für Glutenempfindliche T-Zellen und Verwendung davon
GB9814892D0 (en) 1998-07-10 1998-09-09 Kennedy Rheumatology Inst Treatment of celiac disease
GB0212885D0 (en) * 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof

Also Published As

Publication number Publication date
WO2005099753A1 (en) 2005-10-27
US7854942B2 (en) 2010-12-21
EP1765395B1 (de) 2011-02-09
CA2561800A1 (en) 2005-10-27
CA2561800C (en) 2011-10-18
EP1765395A1 (de) 2007-03-28
US20080003263A1 (en) 2008-01-03
DE602005026287D1 (de) 2011-03-24
EP1765395A4 (de) 2008-06-18

Similar Documents

Publication Publication Date Title
ATE497782T1 (de) Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie
DE602006016444D1 (de) Babynahrung mit hydrolisierten proteinen
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
CY1121332T1 (el) Μiμhtiκα καλσιτονινης προς θεραπεια ασθενειων και διαταραχων
AU2016343738B2 (en) Methods for determination of bioactivity, quantity, removal, or inactivation of cereal amylase trypsin inhibitors in cereals, flours, plants, and complex foods
DK2280721T3 (da) Indoleamin-2, 3-dioxygenasebaseret immunterapi
RU2014143031A (ru) Фрагменты питательных белков и способы их применения
WO2006049756A3 (en) Process for retaining moisture in cooked food with peptide
AR122196A2 (es) Proteína de unión a ilt7, célula huésped, polinucleótido, vector, y métodos relacionados
ATE356878T1 (de) Herstellung von proteinen in eiern
Ahmed et al. Enzymatic crosslinking and food allergenicity: A comprehensive review
BR0110394A (pt) Proteìna anti-congelamento, sequência nucleica, vetor, método para produzir uma proteìna anti-congelamento, organismo geneticamente modificado, extrato contendo proteìna, e, produto alimentìcio
JP2014171424A (ja) オボムコイドアレルゲンを選択的に低減化した卵白素材の製造方法
ATE283642T1 (de) Durch lebensmittel induzierte antisekretorische proteine in eigelb
US20170049136A1 (en) Methods for determination of bioactivity, removal, or inactivation cereal amylase trypsin inhibitors in cereals, flours and complex foods
BR112012031703A2 (pt) materiais proteicos de ovo e lipídocos de ovo isolados, e , métodos para a produção dos mesmos
Zhang et al. Detoxification of Wheat Gluten by Enzymatic Transamidation under Reducing Condition and Its Application in Typical Food Model
EP3947412A4 (de) Entaromatisiertes eiweissisolat, mit proteinisolaten hergestellte produkte und verfahren zu deren herstellung
Hirose et al. Oligoclonal enzyme-linked immunosorbent assay capable of determining the major food allergen, ovomucoid, irrespective of the degree of heat denaturation
Simonato et al. Potential allergens in durum wheat semolina and pasta: fate during cooking and digestion
Kondo et al. Comparison of allergenic properties of salmon (Oncorhynchus nerka) between landlocked and anadromous species
WO2007130285A3 (en) Process for thickening food having reduced oil and fat content
Larijani Sheleri et al. QM/MM studies on the Zn (II)-DPA-protein as the biosensor of P-Tyr onion
Cabanillas et al. Effects of enzymatic hydrolysis on peanut allergenicity
CO2019002504A1 (es) Producto vegetariano tipo hamburguesa con aminoácidos esenciales superiores al huevo (como proteína estándar)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1765395

Country of ref document: EP